Cargando…

Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis

PURPOSE: Tumor Treating Fields (TTFields) therapy, an electric field-based cancer treatment, became FDA-approved for patients with newly diagnosed glioblastoma (GBM) in 2015 based on the randomized controlled EF-14 study. Subsequent approvals worldwide and increased adoption over time have raised th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballo, Matthew T., Conlon, Patrick, Lavy-Shahaf, Gitit, Kinzel, Adrian, Vymazal, Josef, Rulseh, Aaron M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462574/ https://www.ncbi.nlm.nih.gov/pubmed/37493865 http://dx.doi.org/10.1007/s11060-023-04348-w

Ejemplares similares

LMAP-12 TUMOR TREATING FIELDS (TTFIELDS) REAL-WORLD EXPERIENCE IN NEWLY DIAGNOSED GLIOBLASTOMA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS OF OVERALL SURVIVAL
por: Ballo, Matthew T, et al.
Publicado: (2023)

Eighteen years’ experience with tumor treating fields in the treatment of newly diagnosed glioblastoma
por: Vymazal, Josef, et al.
Publicado: (2023)

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines
por: Fishman, Hila, et al.
Publicado: (2023)

Whole brain apparent diffusion coefficient measurements correlate with survival in glioblastoma patients
por: Rulseh, Aaron Michael, et al.
Publicado: (2019)

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields
por: Rulseh, Aaron Michael, et al.
Publicado: (2012)

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
por: Bokstein, Felix, et al.
Publicado: (2020)

In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
por: Blatt, Roni, et al.
Publicado: (2021)

AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
por: Shteingauz, Anna, et al.
Publicado: (2018)

Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2021)

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo
por: Davidi, Shiri, et al.
Publicado: (2022)

Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
por: Kessler, Almuth F., et al.
Publicado: (2018)

First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis
por: Kassubek, Rebecca, et al.
Publicado: (2022)

The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
por: Oberheim-Bush, Nancy Ann, et al.
Publicado: (2022)

Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
Publicado: (2022)

Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study
por: Nishikawa, Ryo, et al.
Publicado: (2023)

Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)
por: Kirson, Eilon D, et al.
Publicado: (2009)

Correction to: Safety and efficacy of Tumor Treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study
Publicado: (2023)

Evaluating the therapeutic effect of tumor treating fields (TTFields) by monitoring the impedance across TTFields electrode arrays
por: Li, Xing, et al.
Publicado: (2022)

Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields)
por: Nickl, Vera, et al.
Publicado: (2022)

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients
por: Guzauskas, Gregory F, et al.
Publicado: (2018)

Temperature and Impedance Variations During Tumor Treating Fields (TTFields) Treatment
por: Gentilal, Nichal, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
por: Vergote, Ignace, et al.
Publicado: (2023)

Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas – a planning study
por: Straube, Christoph, et al.
Publicado: (2018)

Comparison of CT and MR imaging in ischemic stroke
por: Vymazal, Josef, et al.
Publicado: (2012)

Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment
por: Lee, Yeon-Joo, et al.
Publicado: (2020)

Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
por: Voloshin, Tali, et al.
Publicado: (2020)

Kinetic Modeling Reveals a Common Death Niche for Newly Formed and Mature B Cells
por: Shahaf, Gitit, et al.
Publicado: (2010)

Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields])
por: Shams, Shadi, et al.
Publicado: (2022)

Alternating Electric Fields (TTFields) Activate Ca(v)1.2 Channels in Human Glioblastoma Cells
por: Neuhaus, Eric, et al.
Publicado: (2019)

Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959
por: Davidi, Shiri, et al.
Publicado: (2023)

TTFields Prolonged the PFS of Epithelioid Glioblastoma Patient: A Case Report
por: Ding, Yuxuan, et al.
Publicado: (2023)

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
por: Porat, Yaara, et al.
Publicado: (2017)

Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood–Brain Barrier In Vitro and In Vivo
por: Salvador, Ellaine, et al.
Publicado: (2022)

A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights
por: Li, Xing, et al.
Publicado: (2023)

COT-20 Clinical experience with tumor-treating fields therapy for newly diagnosed glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2020)

Does serial administration of gadolinium‐based contrast agents affect patient neurological and neuropsychological status? Fourteen‐year follow‐up of patients receiving more than fifty contrast administrations
por: Vymazal, Josef, et al.
Publicado: (2019)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

Tumour-treating fields (TTFields): Investigations on the mechanism of action by electromagnetic exposure of cells in telophase/cytokinesis
por: Berkelmann, Lukas, et al.
Publicado: (2019)

Tumor Treating Fields for Glioblastoma Treatment: Patient Satisfaction and Compliance With the Second-Generation Optune(®) System
por: Kinzel, Adrian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uh7l0n2e99ce3gv5j0rnsoam65